Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

22 results
Display

Preoperative Evaluation and Postoperative Complications with Prognostic Impact of Surgical Resection for the Hepatocellular Carcinoma in Cirrhotics

Kang KJ

  • KMID: 938251
  • Korean J Hepatol.
  • 2006 Dec;12(4):479-483.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Personalized management of cirrhosis by non-invasive tests of liver fibrosis

Wong GL, Espinosa W, Wong VW

Owing to the high prevalence of various chronic liver diseases, cirrhosis is one of the leading causes of morbidity and mortality worldwide. In recent years, the development of non-invasive tests...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The relation between hepatic venous pressure gradient and complications of liver cirrhosis

Paik YH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Focal nodular hyperplasia-like nodule in liver cirrhosis

Kim H, Park YN

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Spontaneous Bleeding of Multiple Lumbar Arteries in a Patient with Liver Cirrhosis

Hong JS, Jeong WJ, Han YH, Shin SY, Jun JH, Woo YM, Yun JH, Cheon GJ

Esophageal and gastric varix, portal hypertensive gastropathy, Mallory-Weiss tear and gastric ulcer are common causes of bleeding in patients with liver cirrhosis. However, spontaneous arterial bleeding without a history of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Breast Cancer in a Male Patient with Cryptogenic Cirrhosis

Shin SR, Lee MS, Park SH, Choi JS, Lee KM, Kim JB, Kim HS, Kim JW

Breast cancer is a rare disease in men. We report a case of 53-year-old obese male, with known cryptogenic cirrhosis and hepatocellular carcinoma, presenting a tender mass on left breast....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A synchronous hepatocellular carcinoma and renal cell carcinoma treated with radio-frequency ablation

Lee YS, Kim JH, Yoon HY, Choe WH, Kwon SY, Lee CH

Radio-frequency ablation (RFA) is a curative treatment for hepatocellular carcinoma (HCC). Percutaneous RFA has been shown to be beneficial for patients with small renal cell carcinoma (RCC) lacking indications for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Measurement of hepatic venous pressure gradient in liver cirrhosis: Relationship with the status of cirrhosis, varices, and ascites in Korea

Kim MY, Baik SK, Suk KT, Yea CJ, Lee IY, Kim JW, Cha SH, Kim YJ, Um SH, Han KH

BACKGROUND/AIMS: The relationships between the hepatic venous pressure gradient (HVPG) and the status of cirrhosis, complications of portal hypertension and the severity of cirrhosis are not clear. The aim...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B

Cho HJ, Kim SS, Ahn SJ, Park JH, Kim DJ, Kim YB, Cho SW, Cheong JY

BACKGROUND/AIMS: Transferrin and alpha-1 antitrypsin are reportedly associated with liver fibrosis. We evaluated the usefulness of serum transferrin and alpha-1 antitrypsin as new liver fibrosis markers in patients with chronic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Prescription Pattern of Acetaminophen and Non-Steroidal Anti-Inflammatory Drugs in Patients with Liver Cirrhosis

Hong YM, Yoon KT, Heo J, Woo HY, Lim W, An DS, Han JH, Cho M

Analgesics, known to be hepatotoxic drugs, are frequently prescribed to patients with liver cirrhosis who are prone to drug-induced liver injury. No guidelines are available regarding the prescription of analgesics...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites

Kim JJ, Kim JH, Koo JK, Choi YJ, Ko SY, Choe WH, Kwon SY

BACKGROUND/AIMS: The modification of the Model for End-Stage Liver Disease (MELD) scoring system (Refit MELD) and the modification of MELD-Na (Refit MELDNa), which optimized the MELD coefficients, were published in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Prognosis of Liver Cirrhosis in Recent Years in Korea

Kim YS, Um SH, Ryu HS, Lee JB, Lee JW, Park DK, Kim YS, Jin YT, Chun HJ, Lee HS, Lee SW, Choi JH, Kim CD, Hyun JH

The survival of a recent series of 823 cirrhosis patients who were followed up for a mean of 48 months was analyzed. Cirrhosis was ascribed to alcohol (26%), hepatitis virus...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prediction of Hepatic Fibrosis Using Serum Hyaluronic Acid in Patients with Chronic Liver Disease

Kim CW, Yoon SK, Jo BS, Shin JY, Jang JW, Choi JY, Han NI, Lee CD, Chung KW, Sun HS

  • KMID: 1066042
  • Korean J Gastroenterol.
  • 2003 Dec;42(6):510-518.
BACKGROUND/AIMS: The extent of hepatic fibrosis is important in chronic liver disease. Liver biopsy is essential for diagnosis of fibrosis. However, biopsy is invasive and may not represent the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Usefulness of Non-invasive Markers for Predicting Significant Fibrosis in Patients with Chronic Liver Disease

Lee HH, Seo YS, Um SH, Won NH, Yoo H, Jung ES, Kwon YD, Park S, Keum B, Kim YS, Yim HJ, Jeen YT, Chun HJ, Kim CD, Ryu HS

The purpose of this prospective study was to verify and compare the strengths of various blood markers and fibrosis models in predicting significant liver fibrosis. One hundred fifty-eight patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis

Chung JW, Kim GH, Lee JH, Ok KS, Jang ES, Jeong SH, Kim JW

BACKGROUND/AIMS: Portal-vein thrombosis (PVT) develops in 10-25% of cirrhotic patients and may aggravate portal hypertension. There are few data regarding the effects of anticoagulation on nonmalignant PVT in liver cirrhosis....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Successful Treatment of Bleeding Duodenal Varix by Percutaneous Transsplenic Embolization

Kang DH, Park JW, Jeon EY, Kim SE, Kim JH, Kwon YS, Park SA, Park CK

Variceal bleeding occurs primarily in the esophagus or stomach in patients with liver cirrhosis, but can also occur rarely in the duodenum. Duodenal variceal bleeding has a high mortality and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Liver Shear-Wave Velocity and Serum Fibrosis Markers to Diagnose Hepatic Fibrosis in Patients with Chronic Viral Hepatitis B

Liu J, Ji Y, Ai H, Ning B, Zhao J, Zhang Y, Dun G

OBJECTIVE: To compare several noninvasive indices of fibrosis in chronic viral hepatitis B, including liver shear-wave velocity (SWV), hyaluronic acid (HA), collagen type IV (CIV), procollagen type III (PCIII), and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal

Choi YJ, Kim JH, Koo JK, Lee CI, Lee JY, Yang JH, Ko SY, Choe WH, Kwon SY, Lee CH

BACKGROUND/AIMS: A revised classification system for renal dysfunction in patients with cirrhosis was proposed by the Acute Dialysis Quality Initiative and the International Ascites Club Working Group in 2011. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Validation of P2/MS and Other Noninvasive Fibrosis Scoring Systems in the Korean Population with Nonalcoholic Fatty Liver Disease

Yu SJ, Kim D, Lee JH, Chung GE, Yim JY, Park MJ, Kim YJ, Yoon JH, Jang JJ, Lee HS

BACKGROUND/AIMS: P2/MS is a noninvasive marker for detecting hepatic fibrosis in patients with viral hepatitis. However, the applicability of P2/MS in patients with nonalcoholic fatty liver disease (NAFLD) has not...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diagnostic usefulness of the random urine Na/K ratio in cirrhotic patients with ascites: a pilot study

Park JE, Lee CH, Kim BS, Shin IH

BACKGROUND/AIMS: Twenty-four hour urinary sodium excretion (24-h UNa) of greater than 78 mmol/day is important in the management of cirrhotic ascites. Although the random urine sodium-to-potassium ratio (UNa/K) is strongly...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr